Inhibition of HDAC6-dependent carcinogenesis: emerging, new therapeutic options besides belinostat.

Source:http://linkedlifedata.com/resource/pubmed/id/18942705

Int. J. Cancer 2009 Jan 15 124 2 509

Download in:

View as

Triples

General Info

PMID
18942705